Sign Out
Pregnancy: Bevacizumab may cause damage to the unborn baby as it may stop the formation of new blood vessels.
Breastfeeding: Discontinue breastfeeding during the treatment with Bevacizumab and for at least 6 months after the last dose of Bevacizumab as it may interfere with the growth and development of the baby.
Fertility: Bevacizumab may impair fertility.
Continue with Google